Related Experiment Video
Updated: Mar 6, 2026

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.2K
Percutaneous left atrial appendage occlusion: New perspectives for the method.
Iwona Gorczyca-Michta1, Beata Wożakowska-Kapłon
11st Clinic of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Center, Kielce, Poland. iwona.gorczyca@interia.pl.
Cardiology Journal
|March 11, 2017
Summary
Left atrial appendage occlusion offers an alternative stroke prevention method for atrial fibrillation patients unsuitable for oral anticoagulants. Achieving complete closure remains challenging due to anatomical variations, requiring further research on patient selection and post-procedure care.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Ischemic stroke is a significant risk for patients with atrial fibrillation (AF).
- Oral anticoagulants are standard stroke prevention but have contraindications.
- The left atrial appendage is a primary source of thrombi in AF patients.
Purpose of the Study:
- To evaluate percutaneous left atrial appendage occlusion (LAAO) as a stroke prevention strategy.
- To discuss the efficacy and safety of LAAO devices in high-risk AF patients.
- To identify unresolved issues in LAAO therapy.
Main Methods:
- Review of studies investigating percutaneous left atrial appendage occlusion devices since 2002.
- Analysis of safety and efficacy data for various LAAO closure devices.
- Examination of challenges related to variable left atrial appendage anatomy.
Main Results:
- Percutaneous LAAO is a viable option for selected high-risk AF patients.
- Complete closure of the left atrial appendage can be difficult due to anatomical variability.
- Multiple LAAO devices have been developed and studied for safety and efficacy.
Conclusions:
- LAAO is an important therapeutic option for stroke prevention in AF patients with contraindications to anticoagulation.
- Further research is needed on optimal patient selection for LAAO.
- Unresolved issues include complication risks and post-LAAO anticoagulant strategies.

